Board Member
Evolus, Inc. (EOLS)Equibles does not estimate personal net worth.
Get an email with a short summary when Evolus, Inc. publishes a filing, an earnings call transcript or a press release.
Get EOLS alertsDavid Gill is recorded as Board Member at Evolus, Inc. (EOLS) since June 5, 2025. Evolus, Inc. reported in an 8-K filed June 6, 2025 that David Gill was appointed Class I Directors, effective June 5, 2025. Evolus, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Evolus, Inc. includes David Moatazedi (CFO and Board Member), Albert G. White III (Board Member), Albert White III (Board Member) and 3 others.
“The stockholders of the Company elected each of David Gill and Albert White III as Class I Directors for a three-year term ending at the Annual Meeting of Stockholders to be held in 2028 and until each of their successors has been duly elected and qualified, or until their earlier death, resignation or removal.”
2025-06-05–present
EOLS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2025-06-05–present
